Edelinontrine

N/A

Report date: 2025/05/28 16:57:01
NME

Base Information

Drug NameEdelinontrine
Drug Alias NamePDE9iPF-04447943PF-4447943CRD-740
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 9A inhibitors
TargetsPhosphodiesterase 9A
Therapy Area/IndicationsAnemia, Sickle CellHeart Failure, SystolicHeart Failure, Diastolic +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncCardurion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAnemia, Sickle CellHeart Failure, SystolicHeart Failure, Diastolic +[7] 

Other Information

ATC CodeN/A
Related LinksN/A